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OBJECTIVE: Anemia is common in critically ill patients, due to inflammation and
blood loss. Anemia can be associated with iron deficiency and low serum hepcidin
levels. However, iron administration in this setting remains controversial because of
its potential toxicity, including oxidative stress induction and sepsis facilitation. The
objective of this work was to determine the efficacy and toxicity of iron administration
using a mouse model mimicking critical care anemia as well as a model of acute
septicemia. DESIGN: Prospective, randomized, open label controlled animal study.
SETTING: University-based research laboratory. SUBJECTS: C57BL/6 and OF1 mice.
INTERVENTIONS: Intraperitoneal injection of zymosan inducing generalized
inflammation in C57BL/6 mice, followed in our full model by repeated phlebotomies.
A dose equivalent to 15 mg/kg of ferric carboxymaltose was injected intravenously on
day 5. To assess the toxicity of iron in a septicemia model, OF1 mice were
simultaneously injected with iron and different Escherichia coli strains.
MEASUREMENTS AND MAIN RESULTS: To investigate the effect of iron on
oxidative stress, we measured reactive oxygen species production in the blood using
luminol-amplified chemiluminescence and superoxide dismutase 2 messenger RNA
levels in the liver. These markers of oxidative stress were increased after iron
administration in control mice but not in zymosan-treated mice. Liver catalase
messenger RNA levels decreased in iron-treated control mice. Iron administration
was not associated with increased mortality in the septicemia model or in the
generalized inflammation model. Iron increased hemoglobin levels in mice fed with a
low iron diet and subjected to phlebotomies and zymosan 2 wks after treatment
administration. CONCLUSIONS: Adverse effects of intravenous iron supplementation
by ferric carboxymaltose seem to be minimal in our animal models. Furthermore, iron
appears to be effective in correcting anemia, despite inflammation. Studies of efficacy
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